Umlaufvermögen Veränderung Datum
Agenus USD 78.81M 16.47M 2026-06
Amgen USD 34.36B 598M 2026-09
Anika Therapeutics USD 99.19M 5.63M 2026-06
Arrowhead Research USD 1.29B 382.19M 2026-09
AstraZeneca USD 31.45B 3.48B 2026-09
BioMarin Pharmaceutical USD 3.92B 50.99M 2026-09
Bristol-Myers Squibb USD 29.77B 1.19B 2026-09
Celldex Therapeutics USD 663.74M 61.2M 2026-09
Daiichi Sankyo JPY 2.38T 150.33B 2026-09
Eli Lilly USD 65.26B 591M 2026-09
Halozyme Therapeutics USD 1.85B 913.71M 2026-09
Heron Therapeutics USD 209.11M 20.73M 2026-09
Intrexon USD 23.72M 45.04M 2024-06
Ionis Pharmaceuticals USD 2.36B 129.77M 2026-09
Karyopharm Therapeutics USD 126.33M 23.19M 2026-03
Ligand Pharmaceuticals USD 608.23M 848.88M 2026-09
MacroGenics USD 295.08M 26.61M 2026-09
Neurocrine Biosciences USD 2.01B 370.7M 2026-09
Pfizer USD 45.01B 3.65B 2026-09
Regeneron Pharmaceuticals USD 20.8B 2.35B 2026-09
Rigel Pharmaceuticals USD 214.93M 39.53M 2025-09
Sangamo BioSciences USD 49.89M 12.3M 2025-06
Ultragenyx Pharmaceutical USD 544M 62M 2026-09
Veracyte USD 467.88M 106.9M 2026-09